NEW YORK (GenomeWeb News) — Shares in Decode Genetics were up 10 percent, or $.35, at $3.87 after the stock was upgraded by an investment bank
Lehman Brothers upgraded the stock to "equal-weight" from "underweight."
Decode yesterday reported that fourth-quarter revenues increased 17 percent as R&D spending rose 4 percent and lossed increased 10 percent.